Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication

Manuscripts (6 of 6)

Years :

Search manuscripts :


Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
John J.V. McMurray, Robert M. Califf, Angelyn M. Bethel, Steven M. Haffner, Rury R. Holman
The Journal of Clinical Hypertension 2012;14:731. Published:Oct-2012. Epub:26-Jul-2012. PMID:23031154. doi:10.1111/j.1751-7176.2012.00687.x


Incidence of Diabetes Following Ramipril and Rosiglitazone Withdrawal
Rury R Holman FRCP, B Zinman, S Yusaf, P Sheridan, S Anand, J Bosch, I Conget, M Davies, V Pirags, J Pogue, P Zimmet, HC Gerstein.
Diabetes Care 2011;34:1265-1269 . Published:Jun-2011. Epub:22-Apr-2011. PMID:21515846. doi:10.2337/dc10-1567


Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
DREAM Trial Investigators; G.R. Dagenais, H.C. Gerstein, R. Holman, A. Budaj, A. Escalante, T. Hedner, M. Keltai, E. Lonn, S. McFarlane, M. McQueen, K. Teo, P. Sheridan, J. Bosch, J. Pogue, S. Yusuf
Diabetes Care 2008;31:1007-1014. Published:May-2008. Epub:11-Feb-2008. PMID:18268075. doi:10.2337/dc07-1868


Effect of Ramipril on the Incidence of diabetes
Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR for the DREAM Trial Investigators
N Eng J Med 2006;355:1551-62. Published:12-Oct-2006. Epub:15-Sep-2006. PMID:16980380. doi:10.1056/NEJMoa065061

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR on behalf of the DREAM trial investigators
Lancet 2006;368:1096-105. Published:15-Sep-2006. Epub:20-Sep-2006. PMID:16997664. doi:10.1016/S0140-6736(06)69420-8
Erratum in :
Lancet 2006;368:1770


Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial
Gerstein HC, Yusuf S, Holman RR, Bosch J, Pogue J; The DREAM Trial Investigators
Diabetologia 2004;47:1519-1527. Published:Sep-2004. Epub:21-Aug-2004. PMID:15322749. doi:10.1007/s00125-004-1485-5